Skip to content
OpenCapital
Get started

Allarity Therapeutics, Inc. ALLR Q4 2025 Annual earnings

Reported March 31, 2026

Revenue$320.0KIn line
EPS-$0.19Beat by $0.03
Revenue estimate$320.0K
EPS estimate-$0.22

Next report

Aug 21, 2026 (In 3 weeks)
Revenue estimate$25.0K
EPS estimate-$0.25

Versus estimates

Revenue

Q1 2026$25.0KIn line
Q4 2025$320.0KIn line
Q4 2024$6.0K

Diluted EPS

Q1 2026-$0.17Beat by $0.05
Q4 2025-$0.19Beat by $0.03
Q3 2025-$0.19Beat by $0.04Q2 2025-$0.15Beat by $0.06Q1 2025-$0.25Q4 2024-$4.73Beat by $3.37

Ask the moment Allarity Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Allarity Therapeutics, Inc. report Q4 2025 earnings?
Allarity Therapeutics, Inc. (ALLR) reported Q4 2025 earnings on March 31, 2026.
What were Allarity Therapeutics, Inc.'s Q4 2025 revenue and EPS?
Allarity Therapeutics, Inc. reported revenue of $320.0K and eps of $-0.19 for Q4 2025.
Did Allarity Therapeutics, Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $320.0K by -. EPS beat the consensus estimate of $-0.22 by $0.03.
How did Allarity Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5233.3% from $6.0K a year earlier and eps grew 96.0% from $-4.73.
Where can I find Allarity Therapeutics, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001213900-26-038061) and the 10-K periodic report (0001437749-26-010310) directly on SEC EDGAR. The filing index links above go to sec.gov.